- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.07. | ADHERIS HEALTH LIMITED: Becoming a substantial holder | - | ASX | ||
| 31.07. | ADHERIS HEALTH LIMITED: Adheris Health legal claim | - | ASX | ||
| 23.07. | ADHERIS HEALTH LIMITED: 4Q FY26 Quarterly Activity Report and Appendix 4C | - | ASX | ||
| 10.07. | ADHERIS HEALTH LIMITED: Notification of cessation of securities - AHE | - | ASX | ||
| ADHERIS HEALTH Aktie jetzt für 0€ handeln | |||||
| 08.07. | ADHERIS HEALTH LIMITED: Application for quotation of securities - AHE | - | ASX | ||
| 01.07. | ADHERIS HEALTH LIMITED: Appendix 3X - John Murray | - | ASX | ||
| 01.07. | ADHERIS HEALTH LIMITED: Appendix 3Z - Sean Slattery | - | ASX | ||
| 25.06. | ADHERIS HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 12.06. | ADHERIS HEALTH LIMITED: Appointment of John Murray as Non-Executive Director | - | ASX | ||
| 19.05. | ADHERIS HEALTH LIMITED: Appendix 3Y - John Ciccio | - | ASX | ||
| 12.05. | ADHERIS HEALTH LIMITED: Appendix 3Y - John Ciccio | - | ASX | ||
| 29.04. | Adheris Health Q3 FY26 slides: revenue falls as cost cuts accelerate | 1 | Investing.com | ||
| 29.04. | ADHERIS HEALTH LIMITED: Q3 FY26 Results Presentation | - | ASX | ||
| 28.04. | ADHERIS HEALTH LIMITED: 3Q FY26 Quarterly Activity Report and Appendix 4C | - | ASX | ||
| 23.04. | ADHERIS HEALTH LIMITED: Adheris Health 3Q FY26 Results Webinar Invitation | - | ASX | ||
| 22.04. | ADHERIS HEALTH LIMITED: Updated Securities Trading Policy | - | ASX | ||
| 13.04. | ADHERIS HEALTH LIMITED: Change of Company Secretary | - | ASX | ||
| 10.04. | ADHERIS HEALTH LIMITED: Application for quotation of securities - AHE | - | ASX | ||
| 10.04. | ADHERIS HEALTH LIMITED: Notification regarding unquoted securities - AHE | - | ASX | ||
| 10.04. | ADHERIS HEALTH LIMITED: Notification of cessation of securities - AHE | - | ASX |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 62,43 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 47,060 | +0,81 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,510 | +1,05 % | Börse am Morgen: Hensoldt, Puma, Siemens Healthineers, Börsentermine - Nord/LB | Die Zahl der Arbeitslosen in Deutschland ist im Juli m/m spürbar um 71.000 auf 3,007 Mio. gestiegen, die Arbeitslosenquote kletterte um um 0,2 PP auf 6,4%. Neben saisonalen Effekten wie dem Ausbildungsende... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,050 | +0,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 28,140 | +0,14 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BILLIONTOONE | 93,34 | -0,05 % | BillionToOne sinks as outlook unchanged despite surging revenue | ||
| CARL ZEISS MEDITEC | 29,900 | +2,05 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| GENEDX | 77,15 | +0,09 % | Cathie Wood's ARK sells Palantir stock, buys GeneDx Holdings | ||
| ALIGNMENT HEALTHCARE | 14,370 | 0,00 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| BETA BIONICS | 15,900 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,450 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results | 2Q'26 Net Income of $9.0M, +236.7% from 2Q'252Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 10,805 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,400 | -0,16 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,390 | -0,10 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| CONCENTRA GROUP | 33,980 | 0,00 % | Concentra targets $2.325B-$2.375B 2026 revenue and $485M-$495M adjusted EBITDA as CEO transition set for November 1 |
ADHERIS HEALTH LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADHERIS HEALTH LIMITED finden Sie auf Wallstreet Online.